title: Long-term suppression of multidrug-resistant cytomegalovirus retinitis with systemically administered leflunomide.
authors.forename: Jeffrey H
authors.initials: JH
authors.lastname: Dunn
authors.forename: Adriana
authors.initials: A
authors.lastname: Weinberg
authors.forename: Larry K
authors.initials: LK
authors.lastname: Chan
authors.forename: Naresh
authors.initials: N
authors.lastname: Mandava
authors.forename: Marilyn E
authors.initials: ME
authors.lastname: Levi
authors.forename: Jeffrey L
authors.initials: JL
authors.lastname: Olson
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000998:Antiviral Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D003587:Cytomegalovirus / Q000235:genetics; D017726:Cytomegalovirus Retinitis / Q000188:drug therapy* / Q000821:virology; D024921:Drug Resistance, Multiple, Viral / Q000187:drug effects* / Q000235:genetics; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D007555:Isoxazoles / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016030:Kidney Transplantation; D000077339:Leflunomide; D014766:Viremia / Q000188:drug therapy* / Q000821:virology
chemical_list: D000998:Antiviral Agents; D007166:Immunosuppressive Agents; D007555:Isoxazoles; D000077339:Leflunomide